PT Ikapharmindo Putramas Tbk (IDX:IKPM)
Indonesia · Delayed Price · Currency is IDR 194.00
0.00 (0.00%)
Last updated: Sep 2, 2026, 11:51 AM WIB
IDX:IKPM Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 400,249 | 363,565 | 412,069 | 441,137 | 398,735 | 380,917 | |
Revenue Growth | 2.03% | -11.77% | -6.59% | 10.63% | 4.68% | -46.78% |
Cost of Revenue | 230,681 | 216,093 | 226,541 | 252,169 | 217,946 | 203,645 |
Gross Profit | 169,568 | 147,472 | 185,528 | 188,968 | 180,788 | 177,272 |
Selling, General & Admin | 186,543 | 172,085 | 165,389 | 156,810 | 147,732 | 152,267 |
Other Operating Expenses | -2,139 | -127 | 2,625 | 378.47 | -169.92 | - |
Operating Expenses | 184,404 | 171,958 | 168,014 | 157,188 | 147,562 | 152,267 |
Operating Income | -14,836 | -24,485 | 17,514 | 31,780 | 33,226 | 25,005 |
Interest Expense | -12,358 | -12,340 | -10,778 | -11,286 | -11,611 | -12,349 |
Interest & Investment Income | 230.82 | 72.23 | 28.87 | 28.42 | 330.25 | 31.46 |
Currency Exchange Gain (Loss) | 2,977 | 686.55 | 684.62 | -369.61 | 920.19 | 460.5 |
EBT Excluding Unusual Items | -23,986 | -36,067 | 7,449 | 20,153 | 22,866 | 13,148 |
Gain (Loss) on Sale of Investments | - | - | - | - | -115.2 | -2,431 |
Gain (Loss) on Sale of Assets | 519.65 | 570.79 | 585.28 | 631.68 | -30.16 | 1,395 |
Pretax Income | -23,466 | -35,496 | 8,035 | 20,785 | 22,721 | 12,111 |
Income Tax Expense | -6,711 | -6,711 | 3,020 | 5,447 | 6,143 | 3,986 |
Net Income | -16,755 | -28,785 | 5,015 | 15,338 | 16,578 | 8,125 |
Net Income to Common | -16,755 | -28,785 | 5,015 | 15,338 | 16,578 | 8,125 |
Net Income Growth | - | - | -67.30% | -7.48% | 104.02% | 75.56% |
Shares Outstanding (Basic) | 1,685 | 1,685 | 1,685 | 898 | 1,000 | 1,000 |
Shares Outstanding (Diluted) | 1,685 | 1,685 | 1,685 | 898 | 1,000 | 1,000 |
Shares Change | 0.04% | - | 87.63% | -10.21% | - | - |
EPS (Basic) | -9.94 | -17.09 | 2.98 | 17.08 | 16.58 | 8.13 |
EPS (Diluted) | -9.94 | -17.09 | 2.98 | 17.08 | 16.58 | 8.13 |
EPS Growth | - | - | -82.57% | 3.05% | 104.02% | 75.56% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 24,783 | 23,705 | -37,562 | -23,743 | -7,047 | 76,396 |
Free Cash Flow Per Share | 14.71 | 14.07 | -22.30 | -26.45 | -7.05 | 76.40 |
Dividend Per Share | - | - | - | 2.250 | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 42.37% | 40.56% | 45.02% | 42.84% | 45.34% | 46.54% |
Operating Margin | -3.71% | -6.73% | 4.25% | 7.20% | 8.33% | 6.56% |
Profit Margin | -4.19% | -7.92% | 1.22% | 3.48% | 4.16% | 2.13% |
Free Cash Flow Margin | 6.19% | 6.52% | -9.12% | -5.38% | -1.77% | 20.06% |
EBITDA | -7,386 | -16,528 | 25,345 | 41,844 | 43,116 | 36,767 |
EBITDA Margin | -1.85% | -4.55% | 6.15% | 9.49% | 10.81% | 9.65% |
D&A For EBITDA | 7,450 | 7,958 | 7,831 | 10,064 | 9,889 | 11,763 |
EBIT | -14,836 | -24,485 | 17,514 | 31,780 | 33,226 | 25,005 |
EBIT Margin | -3.71% | -6.73% | 4.25% | 7.20% | 8.33% | 6.56% |
Effective Tax Rate | - | - | 37.58% | 26.21% | 27.04% | 32.91% |
Advertising Expenses | - | 69,117 | 62,070 | 55,739 | 50,454 | 81,155 |